Global L-Carnosine Market Research Report 2022
Due to the COVID-19 pandemic, the global L-Carnosine market size is estimated to be worth US$ 25.60 million in 2022 and is forecast to a readjusted size of US$ 33.48 million by 2028 with a CAGR of 4.57% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for 94% of the L-Carnosine global market in 2021, is projected to value US$ 31.92 million by 2028, growing at a revised 4.78% CAGR from 2022 to 2028. While Dietary Supplements segment is altered to an 3.95% CAGR throughout this forecast period.
North America L-Carnosine market size was US$ 3.77 million in 2021, while Europe was US$ 5.57 million. The proportion of the North America was 14.94% in 2021, while Europe’s percentage was 22.06%, and it is predicted that Europe market share will reach 21.45% in 2028, trailing a CAGR of 4.22% through the analysis period. As for the Asia, the notable markets are Japan and South Korea, CAGR is 4.08% and 4.8% respectively for the next 6-year period.
The global major manufacturers of L-Carnosine include Fushilai Pharmaceutical, Hamari Chemicals, Wuhan BJM Pharm Inc., Hubei Huntide Biotech Co.,Ltd, Jiangsu Chengxin Pharmaceutical Co., Ltd, Belle Chemical, KS-V Peptide, Bachem, and Suzhou Tianma Pharmaceutical, etc. In terms of revenue, the global three largest players hold a 70.85% market share of L-Carnosine in 2021.
This report focuses on L-Carnosine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall L-Carnosine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, etc.
Global L-Carnosine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global L-Carnosine Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
By Company
Fushilai Pharmaceutical
Hamari Chemicals
Wuhan BJM Pharm Inc.
Hubei Huntide Biotech Co.,Ltd
Jiangsu Chengxin Pharmaceutical Co., Ltd
Belle Chemical
KS-V Peptide
Bachem
Suzhou Tianma Pharmaceutical
Segment by Type
Purity ≥98%
Purity ≥99%
Segment by Application
Dietary Supplements
Pharmaceutical
Cosmetics and Personal Care
Consumption by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Others
Europe
Germany
France
U.K.
Italy
Spain
Others
South America
Brazil
Others
Middle East and Africa
Middle East
Africa
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook